Breast cancer (BC) is the most frequent form of malignancy and second only to lung cancer
as cause of deaths in women. Notwithstanding many progresses made in the field …

Breast cancer is the most common cancer of women, accounting yearly for approximately
30% of newly diagnosed cases and ranking second as a cause of death. Despite …

Fibroblast growth factor receptors are growth factor receptor tyrosine kinases, exerting their
roles in embryogenesis, tissue homeostasis, and development of breast cancer. Recent …

Simple Summary The fibroblast growth factor/fibroblast growth factor receptor (FGF/FGFR)
system represents an emerging therapeutic target in breast cancer. Here, we discussed …

Developments in breast cancer biology over the last years have permitted deconstructing
the molecular profile of the most relevant breast cancer subtypes. This has led to an …

Fibroblast Growth Factor Receptor (FGFR) signalling plays a critical role in breast embryonal
development, tissue homeostasis, tumorigenesis and metastasis. FGFR, its numerous FGF …

Cancer treatments are increasingly focusing on the molecular mechanisms underlying the
oncogenic processes present in tumors of individual patients. Fibroblast growth factor …

Activation of the fibroblast growth factor receptor pathway is a common event in many cancer
types. Here we review the role of fibroblast growth factor receptor signalling in breast cancer …

Breast cancer (BC) is the most common malignancy and second only to lung cancer in terms
of mortality in women. Despite the incredible progress made in this field, metastatic breast …

FGF receptor (FGFR) signaling is a vital component of both embryonic and postnatal
mammary gland development, which has prompted researchers to investigate both its …